PMA device
Mosaic Neo Mitral Bioprosthesis
Medtronic, Inc. · Replacement Heart-Valve (DYE, Class III) · First FDA decision Mar 3, 2026, newest Mar 3, 2026Aortic stenosisMitral regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Mosaic Neo"
MAUDE reports
9
Brand "Mosaic Neo", since 2015
PubMed studies
0
Mentioning "Mosaic Neo"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Mosaic Neo Mitral Bioprosthesis
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Mosaic Neo Mitral BioprosthesisPMA supplement
P990064-S094 · Decided Mar 3, 2026 · 180 days after receipt · Normal 180 Day Track
Device type: replacement Heart-valve (DYE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Mosaic Neo", any status and sponsor, newest update first.
No registered device study names "Mosaic Neo".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Mosaic Neo", and for the whole product code for context.
This brand
9 reports: 3 malfunction, 6 injury, 0 death
Whole product code DYE
30,601 reports: 1,137 malfunction, 29,078 injury, 359 death
Newest reports for this brand
- MOSAIC NEO BIOPROSTHETIC VALVEMalfunction
Medtronic Heart Valves Division
2025587-2026-01143 · Received Oct 6, 2026 · Event dated Sep 29, 2026
Device type: Replacement Heart-Valve (DYE)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Heart Valves Division
2025587-2026-00975 · Received Sep 1, 2026 · Event dated Aug 6, 2026
Device type: Replacement Heart-Valve (DYE)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
Medtronic Heart Valves Division
2025587-2026-00979 · Received Sep 1, 2026 · Event dated Apr 13, 2026
Device type: Replacement Heart-Valve (DYE)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Heart Block
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1880-2019 · Started May 21, 2019 · Posted by FDA Jun 26, 2019
Reason given: Fifteen affected devices were distributed worldwide, which were mislabeled with an incorrect size. In all cases, the actual surgical heart valves are larger than what was indicated on the boxes and jar labels.
Cause as FDA categorized it: Labeling mix-ups · Device type: Replacement Heart-Valve (DYE)
Z-1881-2019 · Started May 21, 2019 · Posted by FDA Jun 26, 2019
Reason given: Fifteen affected devices were distributed worldwide, which were mislabeled with an incorrect size. In all cases, the actual surgical heart valves are larger than what was indicated on the boxes and jar labels.
Cause as FDA categorized it: Labeling mix-ups · Device type: Replacement Heart-Valve (DYE)
Z-1225-2009 · Started Jan 26, 2009 · Posted by FDA May 29, 2009
Reason given: Medtronic identified several heart valves (Mosaic Porcine Bioprosthesis with Cinch & Hancock II Bioprosthesis with Cinch) that were inadvertently distributed after exposure to temperatures exceeding the 77 F (25 C) maximum storage temperature published on the labeling. The product is being retrieved as they do not...
Cause as FDA categorized it: Storage · Device type: Replacement Heart-Valve (DYE)
Published research
The most relevant PubMed records for "Mosaic Neo"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DYE.
- Carpentier-Edwards PERIMOUNT Magna Pericardial Aortic BioprosthesesEdwards Lifesciences, LLC · PMA 2021
- Carpentier-Edwards Perimount Pericardial Aortic BioprosthesisEdwards Lifesciences, LLC · PMA 2013
- Edwards Prima Plus Stentless Porcine BioprosthesisEdwards Lifesciences, LLC · PMA 2013
- Mosaic Porcine BioprosthesisMedtronic, Inc. · PMA 2006
- Carpentier-Edwards Duraflex Low PressureEdwards Lifesciences, LLC · PMA 2013
- Hancock II Porcine BioprosthesisMedtronic, Inc. · PMA 2013
- Carpentier-Edwards Perimount Plus Pericardial BioprosthesisEdwards Lifesciences, LLC · PMA 2009
- PERIMOUNT Magna Mitral Ease Pericardial BioprosthesisEdwards Lifesciences, LLC · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.